Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Palantir Technologies

Palantir Technologies, Inc. is a holding company, which engages in the development of data integration and software solutions. It operates through the Commercial and Government segments. The Commercial segment offers services to clients in the private sector. The Government segment provides solutions to the United States (US) federal government and non-US governments. The firm offers automotive, financial compliance, legal intelligence, mergers and acquisitions solutions. Its products include Palantir Gotham and Palantir Foundry. The company was founded by Stephen Cohen, Nathan Dale Gettings, Joseph Lonsdale, Alexander C. Karp, and Peter Andreas Thiel in 2003 and is headquartered in Denver, CO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Palantir achieves GAAP profitability, eyes revenue growth in 2023

Palantir's Q4 2022 marked GAAP profitability, strong revenue, and cash generation.
The company's financial position is robust with no debt and $2.6 billion in cash.
Challenges include navigating macroeconomic factors and maintaining profitability.
Opportunities lie in expanding large deals, revenue growth, and operational efficiency.

Palantir Technologies reports record Q1 results, eyes growth opportunities

Palantir Technologies showcased strong financial performance, technological strengths in AI, and a focus on profitability and growth. While facing challenges in achieving profitability and market education, the company is well-positioned to capitalize on opportunities in expanding their customer base and demonstrating the value of their unique products. Overall, Palantir's strategic focus on innovation and client success drives their path towards sustained growth and profitability.

Palantir reports strong profitability, eyes S&P 500 inclusion for growth

Palantir Technologies showcases financial stability and growth with three consecutive quarters of GAAP profitability and strong cash flow.
The company's emphasis on profitability, AI transformation, and customer value propels its positioning as a leading enterprise software company.
Challenges include balancing growth investments with profitability and effectively monetizing AI products for future success.
Opportunities lie in S&P 500 inclusion, market education on AI solutions, and leveraging increased interest in Palantir's products for expansion.

Palantir achieves GAAP profitability, secures key contracts, and drives growth

Palantir's Q3 2023 performance reflects strong growth, profitability, and customer engagement, driven by the success of the Apollo Intelligence Platform and strategic government contracts.
While facing challenges in sustaining growth and managing costs, the company's focus on innovation, AI, and mission-driven culture positions it well for future opportunities.
With a raised revenue guidance, increased R&D investment, and a commitment to excellence, Palantir aims to set industry standards and outperform competitors.

Palantir excels in Q4 2023, poised for revenue growth

Palantir Technologies delivered a robust performance in Q4 2023, showcasing financial strength and market traction through AIP and boot camps.
The company's strengths lie in data integration expertise, organizational alignment, and proven software effectiveness in critical areas.
While challenges in monetization and market competition exist, Palantir has opportunities to drive revenue growth, expand market reach, and strengthen partnerships for sustained success.

Palantir Technologies reports strong Q1 performance amidst internal challenges

Palantir Technologies' Q1 2024 earnings call highlighted robust financial performance, strategic focus on customer alignment, and challenges related to internal disagreements on societal values. The company's commitment to product excellence, growth initiatives, and addressing negative perceptions position it for continued success in the market.

Palantir Technologies excels in Q3 with 30% revenue growth

Palantir Technologies demonstrated strong financial performance in Q3 2024, driven by revenue growth and operational efficiency, positioning the company for continued success.
The company's focus on tangible outcomes, strategic partnerships, and market dominance in the AI revolution underscores its competitive advantage and growth potential.
While facing challenges in maintaining profitability and competitive edge, Palantir has opportunities to capitalize on the AI revolution, expand partnerships, and drive innovation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates under the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Illumina

Microsoft

SAP SE

Splunk

Salesforce

These big data stocks are the needle-movers of the industry and will leverage big data to make our lives easier and much more informed. The post 7 Big Data Stocks That Are Feeding Our Information Addiction appeared first on InvestorPlace.

7 Big Data Stocks That Are Feeding Our Information Addiction

With 2020 coming to an end, here's how PLTR and NIO stock calls have performed this year. And what it means for investing in 2021.

It's Time to Study Palantir and Nio: My Best and Worst Picks in 2020

Airbnb

Etsy

First Republic

Pfizer

PayPal

Teladoc

Verisk Analytics

These best long-term stocks can help boost any diversified portfolio. Here are eight picks with particularly strong potential for the years to come.

The 8 Best Long-Term Stocks with Plenty of Potential

Palantir stock is a contender for the best IPO of 2020. And its recent triangle pattern is providing a low-risk entry.

How To Trade The Triangle Pattern On The Palantir Stock Chart

Palantir stock is once bitten twice shy and learned from prior fiascoes. Click to learn how its savvy strategy keeps it strong.

Palantir's Strategy Is Savvy in the Face of Political Headwinds

Datadog

Elastic N.V

FedEx

JD.com

Block

StoneCo

These growth stocks are riding trends into the new year. Even if you missed out over 2020, it's not too late to get in on the action.

7 ‘Trendy' Growth Stocks That Could Make You Exponentially Richer

Palantir will face significant, negative catalysts and the valuation of Palantir stock is gigantic. The post Palantir Likely to Be Hurt by Competition, Political Issues appeared first on InvestorPlace.

Palantir Likely to Be Hurt by Competition, Political Issues

Own Palantir stock for the long term because it has a huge fan base. The fundamentals are solid and they have long ramp ahead of them.

Palantir Stock Is One to Own For the Long Haul

With shares up more than 106% in a month, investors should be careful with Palantir stock. Upcoming events could reverse its trajectory.

The Recent Hot Run in Palantir Stock Could Cool in 2021

Palantir stock has unfinished business to the upside for its bullish investors. Here's how you should trade it today.

Buy Palantir Stock As It Defies Its Critics Yet Again

Palantir's recent contracts, especially its FDA one, highlight what we've known all along, that big data is an unsolved problem.

Palantir - Coming To Most Things Near You

Morgan Stanley recently downgraded the big-data analytics firm, leading to a drop in Palantir stock and creating an excellent buying opportunity. The post Palantir Is Even More Enticing After the Recent Sell-Off appeared first on InvestorPlace.

Palantir Is Even More Enticing After the Recent Sell-Off

After Palantir's more than 200% rally since its market debut, it may be wise to take some money off the table, Strategic Wealth Partners' Mark Tepper said.

Time to take ‘some profits' on Palantir after monster rally, trader says

The stock price of Palantir Technologies Inc (NYSE: PLTR) is trading at more than 25% over the past week as it went from $22.20 per share on December 2 to $28.76 ( as of 2:51 PM ET). This is why.

Palantir Stock Price Increases Over 25% This Week: Why It Happened

Palantir's push into federal health work continues. The data analytics company just picked up a new U.S. Food and Drug Administration contract which will span three years for a total of $44.4 million.

Palantir will soon help the FDA evaluate drugs, including COVID-19 treatments

If you get Japan right, you're going to be a more disciplined, better company for it, write Phil Wickham and Koichiro Nakamura.

Outside the Box: How Palantir's early experience in Japan helped set up its successful IPO

DENVER--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE:PLTR) announced today it was awarded a $44.4m, three-year contract with the U.S. Food and Drug Administration (FDA). The contract will build on Palantir's existing partnership with the FDA by providing an enterprise data management and analytics solution for the Center for Drug Evaluation and Research (CDER) and the Oncology Center of Excellence (OCE), amongst their other technology investments. This contract represents Palantir's larges

Palantir Technologies Expands FDA Partnership With $44m Contract

It's not the first time the assertive company has inked a services deal with a federal healthcare agency.

Palantir Wins $44 Million FDA Contract for Drug Review Technology

Data analytics company Palantir Technologies Inc was awarded a $44.4 million contract by the U.S. Food and Drug Administration, a Palantir spokeswoman said, sending its shares up around 21%.

Palantir wins $44 million FDA contract, boosting shares 21%

One of the hottest new offerings of 2020 has been Palantir Technologies (NASDAQ: PLTR), with shares up nearly 200% since its IPO. What Happened: Palantir's stock surged Monday following a Bloomberg report of the company landing a three-year, $44-million contract with the U.S. Food and Drug Administration.

Palantir Shares Surge On Report Of $44M FDA Contract

Long-term contracts provide Palantir with meaningful visibility well into 2021. Palantir is not a fast growing company, but one with very steady and recurring revenues.

Palantir: Still Upside Potential

The deal is worth $44.4 million and will focus on powering drug reviews and inspections, according to the report.

Palantir jumps 17% on report of $44 million FDA contract

Bank of America

Netflix

Tesla

NVIDIA

If you want to learn about a safer way to play the market, start with this list of the best stocks for trading options right now. The post The 5 Best Stocks for Trading Options appeared first on InvestorPlace.

The 5 Best Stocks for Trading Options

Palantir surged as much as 17% on Monday following a Bloomberg report that said the data-mining firm won a three-year contract with the US Food and Drug Administration. The contract is worth $44.4 million, Bloomberg said, adding that it will allow the FDA to utilize Palantir's software to integrate and analyze data.

Palantir surges 17% after it wins FDA contract worth $44 million, report says (PLTR)

PLTR stock is surging even higher after Palantir just landed a three-year contract with the U.S. Food and Drug Administration. The post Palantir Stock Surges on FDA Contract Victory appeared first on InvestorPlace.

News for Palantir Technologies Stock (PLTR)